Total Capacity
240,000 L
(15,000 L x 12 10,000 L x 6)
-
2024
-
AUG.
Joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner
-
JUN.
Launch of intensified cell culture platform, S-Tensify™
-
MAR.
Received A- rating “Honors Award” in carbon management sector by CDP awards
-
JAN.
Awarded the Platinum Sustainability Rating from EcoVadis
-
AUG.
-
2023
-
NOV.
Launch of proprietary TGE platform, S-CHOsient™
-
AUG.
Launch of Customized CMC service, SelecTailor™
-
JUN.
Plant 4 CGMP ready
- PLANT
4
Construction
31 months to
CGMP ready - PLANT
-
APR.
Plant 5 groundbreaking
-
MAR.
SBA New Jersey opening
Pfizer manufacturing partnership
-
JAN.
Received Terra Carta Seal
for commitment to sustainability
-
NOV.
-
2022
-
OCT.
Plant 4 completion
ISO 37001 Certification
(Anti-bribery Management Systems)Launch of proprietary platforms,
S-DUAL™ & DEVELOPICK™ -
AUG.
Received Frost & Sullivan’s
“Enlightened Growth Leadership” Award -
APR.
Full acquisition of Samsung Bioepis
-
OCT.
-
2021
-
DEC.
ISO 9001 Certification
(Quality Management System) -
MAY.
ISO Certifications:
14001 (Environmental Management System)
22301 (Business Continuity Management System)
45001 (Health & Safety Management System)
50001 (Energy Management System) -
APR.
10th Anniversary
-
DEC.
-
2020
-
NOV.
Plant 4 groundbreaking
-
OCT.
SBA San Francisco opening
-
AUG.
Launch of proprietary cell line development platform,
S-CHOice® -
MAY.
ISO 22301 Certification for Plant 3
(Business Continuity Management System) -
APR.
Manufacturing Partnership with Vir for its COVID-19 treatment
-
NOV.
-
2019
-
NOV.
ISO 27001 Certification
(Information Security Management System)
-
NOV.
-
2018
-
OCT.
AEO (Authorized Economic Operator) Certification
Plant 3 CGMP Ready
- PLANT
3
Total Capacity
180,000 L
(12x15,000 L)Construction
34 months to
CGMP ready - PLANT
-
APR.
ISO 22301 Certification for Plant 1,2
(Business Continuity Management System)
-
OCT.
-
2017
-
DEC.
First Approval of Plant 2 by EMA
-
SEP.
First Approval of Plant 2 by FDA
-
MAY.
First Approval of Plant 1 by PMDA
-
DEC.
-
2016
-
NOV.
Samsung Biologics IPO on KOSPI
-
JUL.
First Approval of Plant 1 by EMA
-
FEB.
Plant 2 DS CGMP Ready
- PLANT
2
Total Capacity -
154,000L
(10x15,000 L /
4x1,000 L)Construction -
29 months
to CGMP ready - PLANT
-
NOV.
-
2015
-
DEC.
Plant 3 groundbreaking
-
NOV.
First Approval of Plant 1 by FDA
-
DEC.
-
2014
-
APR.
DP Manufacturing Partnership with BMS
-
APR.
-
2013
-
OCT.
Roche manufacturing partnership
-
SEP.
Plant 2 groundbreaking
-
AUG.
Plant 1 DP CGMP Ready
-
JUL.
BMS manufacturing partnership
-
JUN.
Plant 1 DS CGMP Ready
- PLANT
1
Total Capacity -
30,000 L
(6x5,000 L)Construction -
25 months
to CGMP ready - PLANT
-
OCT.
-
2012
-
JUL.
Plant 1 Mechanical Completion
-
JUL.
-
2011
-
MAY.
Plant 1 groundbreaking
-
APR.
Foundation of Samsung Biologics
-
MAY.